申请人:CETUS ONCOLOGY CORPORATION
公开号:EP0247860A2
公开(公告)日:1987-12-02
A pharmaceutical composition is prepared utilizing biologically active, selectively conjugated TNF. The conjugation is of TNF to a water-soluble polymer selected from polyethylene glycol polymers or polyoxyethylated polyols, which polyethylene glycol polymer is unsubstituted or substituted at one end with an alkyl group and which polyol is unsubstituted.
利用具有生物活性的选择性共轭 TNF 制备药物组合物。TNF与选自聚乙二醇聚合物或聚氧乙烯多元醇的水溶性聚合物共轭,聚乙二醇聚合物未被取代或一端被烷基取代,多元醇未被取代。